強力なMRIスキャンが治療抵抗性てんかんの外科手術を可能に(Powerful new MRI scans enable life-changing surgery in first for adults with epilepsy)

ad

2025-03-21 ケンブリッジ大学

ケンブリッジ大学とパリ・サクレー大学の研究チームは、超高磁場7テスラMRIと「パラレルトランスミット」技術を用い、従来のMRIでは識別困難だった薬剤耐性てんかん患者の脳病変を可視化することに成功した。31名の患者を対象にした臨床試験では、9名で新たな病変を発見し、合計18名(58%)の治療方針が変更された。これにより多くの患者が外科手術やレーザー治療、または精密な脳波測定(sEEG)を受ける機会を得た。この技術は、てんかん治療において大きな前進であり、病変の正確な位置特定による治癒の可能性を広げるものである。

<関連情報>

成人てんかんの手術前評価のための並列送信 7T MRI Parallel transmit 7T MRI for adult epilepsy pre-surgical evaluation

Krzysztof Klodowski, Minghao Zhang, Jian P. Jen, Daniel J. Scoffings, Robert Morris, Victoria Lupson, Franck Mauconduit, Aurélien Massire, Vincent Gras, Nicolas Boulant …
Epilepsia  Published: 20 March 2025
DOI:https://doi.org/10.1111/epi.18353

強力なMRIスキャンが治療抵抗性てんかんの外科手術を可能に(Powerful new MRI scans enable life-changing surgery in first for adults with epilepsy)

Abstract

Objective
To implement parallel transmit (pTx) 7T magnetic resonance imaging (MRI) in the pre-surgical evaluation of 3T-negative patients with drug-resistant focal epilepsy, and to compare quality to conventional single transmit (specifically, circularly polarized [CP]) 7T MRI.

Methods
We implemented a comparative protocol comprising both pTx and CP 7T MRI in consecutive adult candidates for epilepsy surgery who had negative or equivocal 3T MRI imaging. Here we report the outcomes from the first 31 patients. We acquired pTx and CP T1, T2, fluid-attenuated inversion recovery (FLAIR) and edge-enhancing gradient echo (EDGE) images, all in the same three-dimensional (3D) 0.8 mm isotropic space. Two-dimensional (2D) high-resolution T2 and T2*-weighted sequences were acquired only in CP mode due to current technological limitations. Two neuroradiologists, a neurologist, and a neurosurgeon made independent, blinded quality and preference ratings of pTx vs CP images. Quantitative methods were used to assess signal dropout.

Results
7T revealed previously-unseen structural lesions in nine patients (29%), confirmed 3T-equivocal lesions in four patients (13%), and disproved 3T-equivocal lesions in four patients (13%). Lesions were better visualized on pTx than CP in 57% of cases, and never better visualized on CP. Clinical management was altered by 7T in 18 cases (58%). Nine cases were offered surgical resection and one laser interstitial thermal therapy (LITT). Three cases were removed from the surgical pathway because of bilateral or extensive lesions. Five cases were offered stereo-electroencephalography (sEEG) with better targeting (in three because the 7T lesion was deemed equivocal by the multi-disciplinary team (MDT), and in two because the lesion was extensive). Blinded comparison confirmed significantly better overall quality of pTx FLAIR images (F(2, 184) = 13.7, p = 2.88 × 10-6), whereas pTx MP2RAGE images were subjectively non-inferior and had improved temporal lobe coverage with quantitatively less signal drop-out.

Significance
pTx-7T is implementable in a clinical pathway, changed management in 58% of patients where 3T + FDG-PET had not enabled resection, and is superior to single transmit 7T MRI.

Key points

  • We scanned 31 patients with parallel transmit and conventional 7T magnetic resonance imaging (MRI), finding previously-unreported structural lesions in nine patients (29% of cases).
  • In 13% of cases, 7T MRI showed that an equivocal lesion at 3T MRI was likely significant.
  • In 13% of cases, 7T MRI showed that an equivocal lesion at 3T MRI could be disregarded.
  • Both qualitative and quantitative quality assessments indicate superiority of pTx images over circularly polarized (CP).
  • Future clinical implementations of 7T MRI for epilepsy should utilize parallel transmit where possible.
医療・健康
ad
ad
Follow
ad
タイトルとURLをコピーしました